ΒΙΒΛΙΟΓΡΑΦΙΑ 1.
Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324:71– 86
2.
Helgason CM, Bolin KM, Hoff JA, Winkler SR, Mangat A, Tortorice KL, et al . Development of aspirin resistance in persons with previous ischaemic stroke. Stroke 1994; 25:2331-6.
3.
S A. D. Michelson, M. Cattaneo, J. W. Eikelboom, et al., “Aspirin resistance: position paper of the Working Group on Aspirin Resistance,” Journal of Thrombosis and Haemostasis 2005; 3 1309–1311.
4.
G. J. Hankey and J. W. Eikelboom, “Aspirin resistance,” The Lancet 2006; 367 606–617.
4.
N Zimmermann, M. Kurt, A. Wenk, J. Winter, E. Gams, and T. Hohlfeld, “Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?,” European Journal of Cardio-Thoracic Surgery 2005; 27 606–610.
5.
Pamukcu B. A review of aspirin resistance; definition, possible mechanisms, detection with platelet function tests, and its clinical outcomes. J Thromb Thrombolysis 2007; 23:213–22.
6.
Weber AA, Przytulski B, Schanz A, Hohefeld T, Schror K. Towards a definαtion of aspirin resistance: a typological approach. Platelets 2002 ; 13:37-40.
7.
Fitzgerald R, Pirmohamed M. Aspirin resistance: Effect of clinical, biochemical and genetic factors. Pharmacol Ther. 2011; 130:213-25.
8.
Coma-Canella I, Velasc A. Variability in individual responsiveness to aspirin: clinical implications and treatment. Cardiovasc Hematol Disord Drug Targets. 2007; 7:274-87.
9.
Papathanasiou A, Goudevenos J, Tselepis AD. Aspirin resistance in cardiovascular disease: pathogenesis, diagnosis and clinical impact. Curr Pharm Des. 2009; 15:1085-94.
10. Mehta JL, Mohandas B. Aspirin resistance: Fact or fiction? A point of view. World J Cardiol. 2010; 2:280-8. 11. Kei AA, Florentin M, Mikhailidis DP, Elisaf MS, Liberopoulos EN. Review: Antiplatelet drugs: what comes next? Clin Appl Thromb Hemost. 2011; 17:9-26. 12. Foussas SG, Zairis MN, Tsirimpis VG, Makrygiannis SS, Patsourakos NG, Adamopoulou EN, Mytas DZ, Prekates AA, Perdiou AJ, Tsoukanas VK, Argyrakis SK. The impact of aspirin resistance on the long-term cardiovascular mortality in patients with non-ST segment elevation acute coronary syndromes. Clin Cardiol. 2009; 32:142-7.
132